Scitara raises $5M to develop its DLX platform

By The Science Advisory Board staff writers

January 28, 2021 -- Scitara has raised $5 million in series A financing that it plans to use to fully develop its Digital Lab Exchange (DLX) platform.

Scitara DLX connects any device, instrument, application, informatics system, or web service, and automates workflows and task notifications, the company said.

The investment round was led by Northpond Ventures, a representative of which will join Scitara's board of directors, according to the firm.

Sestina Bio to develop digital cell engineering platform
Sestina Bio, a new company developing an automated synthetic biology platform, has been launched with seed funding. Sestina also is the first company...
Amazon powers Moderna's digital biotech platform
Amazon Web Services is providing cloud, analytics, and machine-learning services to Moderna for its messenger RNA platform and manufacturing facility.

Copyright © 2021

Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter